Lovastatin may up-regulate expression of muscarinic acetylcholine receptors and against the neurotoxicity of β-amyloid peptide on the receptors

谭龙春,赵亮,邓成敏,刘仙红,官志忠

DOI: https://doi.org/10.3969/j.issn.1005-9202.2017.10.008

2017-01-01

Abstract:Objective To investigate the influence of lovastatin on muscarinic acetylcholine receptors (mAChRs),and reveal whether the drug attenuate the inhibited effect of-amyloid peptide (Aβ) on the receptors.Methods The primary cultured rat hippocampal neurons and SH-SY5Y cells were exposed to lovastatin and Ab oligomers (AβOs) with alone or both treatments for 24~48 h.The protein levels of M1 and M3 mAChR were examined by Western blot,and the mRNA levels were tested by Real-time PCR.Results The purity of primary cultured rat hippocampal neurons was over 85%;by exposures of different concentrations of lovastatin for 24 h,the protein and mRNA levels of M1 and M3 mAChR were higher than those of control group,respectively (P<0.05);as compared with those of control group,the protein and mRNA levels of M1 and M3 mAChR were obviously decreased in the treatment with 0.5 μmol/L AβOs for 48 h (P<0.05);while the cells were pretreated with 0.1 μmol/L lovastatin for 24 h before the treatments by AβOs,the decreased protein and mRNA levels of M1 and M3 mAChR were all alleviated.Conclusions Lovastatin might up-regulate expression of mAChRs and attenuate the inhibited effect of Aβ on the receptors.